Income statement
CAD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 80K | 26K | 24K | 139K | 4K |
| Gross Profit | -27K | 25K | 24K | 63K | 4K |
| Operating Income | -1M | -1M | -4M | -6M | -9M |
| EBITDA | -3M | -2M | -4M | -6M | -9M |
| Net Income | -3M | -2M | -4M | -6M | -9M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.034
+0.00% today
1Y Change
-57.50%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Therma Bright Inc. (TBRIF) is a Healthcare stock with listed on OTC. The stock last traded around $0.03 and down 57.5% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +207.9%, EPS growth of -616.7%, a dividend yield of 0.0%. What stands out right now is revenue +207.9%, EPS -616.7%, free cash flow +89.5% with operating margin -1761.2% and ROIC 66.3%. Valuation already assumes a fairly strong business story at price/sales 51.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TBRIF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TBRIF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TBRIF Max Drawdown
-67.50%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TBRIF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$3.9K
-97.2% YoY
FY Net Income
-$8.6M
-46.4% YoY
Free Cash Flow
-$3.2M
+17.0% YoY
Revenue Growth
+207.9%
EPS Growth
-616.7%
Gross Margin
22.1%
Net Margin
-5884.3%
Income statement
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 80K | 26K | 24K | 139K | 4K |
| Gross Profit | -27K | 25K | 24K | 63K | 4K |
| Operating Income | -1M | -1M | -4M | -6M | -9M |
| EBITDA | -3M | -2M | -4M | -6M | -9M |
| Net Income | -3M | -2M | -4M | -6M | -9M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1K | 1K | 182K | 3M | 2M |
| Total Assets | 180K | 3M | 2M | 4M | 2M |
| Total Liabilities | 2M | 2M | 2M | 1M | 927K |
| Shareholder Equity | -2M | 1M | 45K | 3M | 1M |
| Total Debt | 40K | 65K | 90K | 111K | 40K |
| Net Debt | 39K | 64K | -92K | -3M | -2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3M
+24.9% YoY
Capital Expenditures
300K
Free Cash Flow
3M
+17.0% YoY
Key ratios
Gross Margin
22.1%
Operating Margin
-1761.2%
Net Margin
-5884.3%
ROE
420.7%
Debt / Equity
-0.02x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.